The estimated Net Worth of Scott M Storer is at least $2.41 million dollars as of 12 February 2018. Scott Storer owns over 3,972 units of Momenta Pharmaceuticals stock worth over $2,350,212 and over the last 8 years Scott sold MNTA stock worth over $60,216.
Scott has made over 1 trades of the Momenta Pharmaceuticals stock since 2018, according to the Form 4 filled with the SEC. Most recently Scott sold 3,972 units of MNTA stock worth $60,216 on 12 February 2018.
The largest trade Scott's ever made was selling 3,972 units of Momenta Pharmaceuticals stock on 12 February 2018 worth over $60,216. On average, Scott trades about 1,986 units every 0 days since 2016. As of 12 February 2018 Scott still owns at least 44,783 units of Momenta Pharmaceuticals stock.
You can see the complete history of Scott Storer stock trades at the bottom of the page.
Scott's mailing address filed with the SEC is C/O MOMENTA PHARMACEUTICALS, INC., 675 WEST KENDALL STREET, CAMBRIDGE, MA, 02142.
Over the last 20 years, insiders at Momenta Pharmaceuticals have traded over $110,027,424 worth of Momenta Pharmaceuticals stock and bought 827,300 units worth $5,505,611 . The most active insiders traders include Christoph H Westphal, Craig A Wheeler et Peter Barrett. On average, Momenta Pharmaceuticals executives and independent directors trade stock every 6 days with the average trade being worth of $448,442. The most recent stock trade was executed by Ian Fier on 20 August 2020, trading 1,808 units of MNTA stock currently worth $94,323.
Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA.
Momenta Pharmaceuticals executives and other stock owners filed with the SEC include: